Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2020

View Archived Issues

AHR inhibition suppresses Zika infection

[124/131I]-MSK-PSMA1, a new radioiodinated theranostic agent for PSMA-positive prostate cancer

[89Zr]DFO-elotuzumab as novel imaging agent in patients with MM

EBV drives gastric cancer by rewiring host epigenomes

Suzhou Zelgen Biosciences identifies new MAP3K5 inhibitors

Dihydroorotate dehydrogenase inhibitors discovered at Janssen

Cascade (Shanghai) Pharmaceutical Technology patents AMPK activators

New PDE9 inhibitors synthesized at Nanjing TransThera Biosciences

Gruenenthal presents glucocorticoid receptor modulators

Series A financing to support ExeVir's development of VHH-72-Fc for COVID-19

Enrollment starts in phase IIa study of tegavivint in desmoid tumors

PIK3C2B blockade protects against ischemic stroke and preserves vascular integrity

FDA clears first IND application for RLS-0071

Reata announces investigator-sponsored trial of bardoxolone in patients with COVID-19

First patient dosed in investigator-initiated study of infigratinib in recurrent glioblastoma

European Commission grants approval for Xenleta as treatment of CAP

COVACTA trial of Actemra in severe COVID-19-associated pneumonia misses endpoints

Phase III REFALS trial of oral levosimendan in ALS does not meet endpoints

Mucolipin-1 is a therapeutic target in Alzheimer's disease

Krystal begins phase III study of beremagene geperpavec for dystrophic epidermolysis bullosa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...